KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Acquisitions: 2022-2024

Historic Acquisitions for Regeneron Pharmaceuticals (REGN) over the last 3 years, with Dec 2024 value amounting to $16.5 million.

  • Regeneron Pharmaceuticals' Acquisitions was N/A to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.4 million, marking a year-over-year change of. This contributed to the annual value of $16.5 million for FY2024, which is 69.95% down from last year.
  • Regeneron Pharmaceuticals' Acquisitions amounted to $16.5 million in FY2024, which was down 69.95% from $54.9 million recorded in FY2023.
  • In the past 5 years, Regeneron Pharmaceuticals' Acquisitions ranged from a high of $230.3 million in FY2022 and a low of $16.5 million during FY2024.
  • Its 3-year average for Acquisitions is $100.6 million, with a median of $54.9 million in 2023.
  • Data for Regeneron Pharmaceuticals' Acquisitions shows a maximum YoY plummeted of 76.16% (in 2023) over the last 5 years.
  • Regeneron Pharmaceuticals' Acquisitions (Yearly) stood at $230.3 million in 2022, then plummeted by 76.16% to $54.9 million in 2023, then slumped by 69.95% to $16.5 million in 2024.